# Cloverleaf Bio, Inc.

Canonical: https://abierto.us/vendors/cloverleaf-bio-inc-nr4gywz66hm5

- UEI: NR4GYWZ66HM5
- CAGE: 0QEA6
- Location: New Haven, CT
- Awards in window: 1 (1 transactions), -$55,000 obligated, September 9, 2026 to September 9, 2026

## Awarding agencies

- National Institutes of Health: 1 awards, -$55,000

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): -$55,000

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- 75N91025C00020 (definitive contract): -$55,000, NIH NCI. Eo 14398 SBIR FY25 Concept Award: Development of Engineered Trna Therapeutics for Clear Cell Renal Cell Carcinoma. https://www.usaspending.gov/award/CONT_AWD_75N91025C00020_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/cloverleaf-bio-inc-nr4gywz66hm5.